acetazolamide has been researched along with Branch Vein Occlusion in 7 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine and compare the efficacy of intravitreal bevacizumab (IVB) and oral acetazolamide (OA) combination therapy versus IVB monotherapy in patients with macular edema secondary to retinal vein occlusion (RVO)." | 9.69 | Acetazolamide and bevacizumab combination therapy versus bevacizumab monotherapy in macular edema secondary to retinal vein occlusion. ( Abtahi, SH; Ansari, I; Barkhordari, S; Karimi, S; Nafisi, H; Nikkhah, H; Nouri, H; Samnejad, S, 2023) |
| "To evaluate the variations of preretinal oxygen partial pressure (Po(2)) in normal and in ischemic postexperimental branch retinal vein occlusion (BRVO) areas, during normoxia, hyperoxia (100% O(2)), and carbogen (95% O(2), 5% CO(2)) breathing before and after intravenous injection of acetazolamide." | 7.72 | Experimental retinal vein occlusion: effect of acetazolamide and carbogen (95% O2/5% CO2) on preretinal PO2. ( Munoz, JL; Petropoulos, IK; Pournaras, CJ; Pournaras, JA, 2004) |
| "In a prospective study, 41 patients with documented chronic macular edema of various causes were entered into a therapeutic trial of acetazolamide sodium, a carbonic anhydrase inhibitor." | 7.67 | Treatment of chronic macular edema with acetazolamide. ( Bird, AC; Cox, SN; Hay, E, 1988) |
| "To determine and compare the efficacy of intravitreal bevacizumab (IVB) and oral acetazolamide (OA) combination therapy versus IVB monotherapy in patients with macular edema secondary to retinal vein occlusion (RVO)." | 5.69 | Acetazolamide and bevacizumab combination therapy versus bevacizumab monotherapy in macular edema secondary to retinal vein occlusion. ( Abtahi, SH; Ansari, I; Barkhordari, S; Karimi, S; Nafisi, H; Nikkhah, H; Nouri, H; Samnejad, S, 2023) |
| "To evaluate the variations of preretinal oxygen partial pressure (Po(2)) in normal and in ischemic postexperimental branch retinal vein occlusion (BRVO) areas, during normoxia, hyperoxia (100% O(2)), and carbogen (95% O(2), 5% CO(2)) breathing before and after intravenous injection of acetazolamide." | 3.72 | Experimental retinal vein occlusion: effect of acetazolamide and carbogen (95% O2/5% CO2) on preretinal PO2. ( Munoz, JL; Petropoulos, IK; Pournaras, CJ; Pournaras, JA, 2004) |
| "In a prospective study, 41 patients with documented chronic macular edema of various causes were entered into a therapeutic trial of acetazolamide sodium, a carbonic anhydrase inhibitor." | 3.67 | Treatment of chronic macular edema with acetazolamide. ( Bird, AC; Cox, SN; Hay, E, 1988) |
| "Multiple sclerosis is associated with iridocyclitis, intermediate uveitis, retinal periphlebitis, and optic neuritis." | 1.37 | Bilateral rubeosis iridis and rubeotic glaucoma due to peripheral occlusive vasculitis associated with multiple sclerosis. ( Deane, J; Dharmasena, A; Turner, SJ, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Karimi, S | 1 |
| Nikkhah, H | 1 |
| Nafisi, H | 1 |
| Nouri, H | 1 |
| Ansari, I | 1 |
| Barkhordari, S | 1 |
| Samnejad, S | 1 |
| Abtahi, SH | 1 |
| Turner, SJ | 1 |
| Dharmasena, A | 1 |
| Deane, J | 1 |
| Pournaras, JA | 1 |
| Petropoulos, IK | 1 |
| Munoz, JL | 1 |
| Pournaras, CJ | 1 |
| Abruzzo, T | 1 |
| Melson, MR | 1 |
| Halton, LC | 1 |
| Newman, NJ | 1 |
| Hudgins, PA | 1 |
| Biousse, V | 1 |
| Krott, R | 1 |
| Heller, R | 1 |
| Aisenbrey, S | 1 |
| Bartz-Schmidt, KU | 1 |
| Ravalico, G | 1 |
| Battaglia Parodi, M | 1 |
| Cox, SN | 1 |
| Hay, E | 1 |
| Bird, AC | 1 |
1 trial available for acetazolamide and Branch Vein Occlusion
| Article | Year |
|---|---|
Acetazolamide and bevacizumab combination therapy versus bevacizumab monotherapy in macular edema secondary to retinal vein occlusion.
Topics: Acetazolamide; Angiogenesis Inhibitors; Bevacizumab; Humans; Intravitreal Injections; Macula Lutea; | 2023 |
6 other studies available for acetazolamide and Branch Vein Occlusion
| Article | Year |
|---|---|
Bilateral rubeosis iridis and rubeotic glaucoma due to peripheral occlusive vasculitis associated with multiple sclerosis.
Topics: Acetazolamide; Adult; Glaucoma, Neovascular; Humans; Immunosuppressive Agents; Iritis; Light Coagula | 2011 |
Experimental retinal vein occlusion: effect of acetazolamide and carbogen (95% O2/5% CO2) on preretinal PO2.
Topics: Acetazolamide; Animals; Carbon Dioxide; Carbonic Anhydrase Inhibitors; Hyperoxia; Injections, Intrav | 2004 |
MRI findings in isolated spontaneous thrombosis of the superior ophthalmic vein.
Topics: Acetazolamide; Adult; Blindness; Diuretics; Exophthalmos; Female; Humans; Intraocular Pressure; Lupu | 2007 |
Adjunctive hyperbaric oxygenation in macular edema of vascular origin.
Topics: Acetazolamide; Aged; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diuretics; Emergencies; F | 2000 |
Exudative retinal detachment subsequent to retinal vein occlusion.
Topics: Acetazolamide; Aged; Aged, 80 and over; Exudates and Transudates; Female; Fluorescein Angiography; F | 1992 |
Treatment of chronic macular edema with acetazolamide.
Topics: Acetazolamide; Chronic Disease; Dose-Response Relationship, Drug; Eye Diseases; Fluorescein Angiogra | 1988 |